Treatment Protocol for High-Risk PNET Brain Tumors in Children With Surgery, Sequential Chemotherapy, Conventional and High-Dose With Peripheral Blood Stem Cell Transplantation and Radiation Therapy
Phase 2
N/A
10 Years
N/A
10 Years
Open (Enrolling)
Both
Medulloblastoma, Brain Tumors, Neuroectodermal Tumors, Primitive
Both
Medulloblastoma, Brain Tumors, Neuroectodermal Tumors, Primitive
Trial Information
Treatment Protocol for High-Risk PNET Brain Tumors in Children With Surgery, Sequential Chemotherapy, Conventional and High-Dose With Peripheral Blood Stem Cell Transplantation and Radiation Therapy
Inclusion Criteria:
- Medulloblastoma in patients less than 5 years of age
- Brain PNET in patients less than 10 years of age
- Histologically documented diagnosis
- Body weight of > 8 kg
Exclusion Criteria:
- Parents' refusal
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Response of medulloblastoma metastases to the chemotherapy regimen in children less than 5 years of age
Principal Investigator
Chantal Kalifa, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Gustave Roussy, Cancer Campus, Grand Paris
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
PNET HR
NCT ID:
NCT00180791
Start Date:
July 2002
Completion Date:
Related Keywords:
- Medulloblastoma
- Brain Tumors
- Neuroectodermal Tumors, Primitive
- Brain PNET
- Brain Neoplasms
- Medulloblastoma
- Neuroectodermal Tumors
- Neuroectodermal Tumors, Primitive
Name | Location |
|---|
